Condition
Ventricular Arrhythmia clinical trials and research
As of November 12, 2026, Find a Trial lists 11 Ventricular Arrhythmia clinical trials that are recruiting, at sites in 8 countries (most in United States (3), Italy (3), Spain (3)). By phase: Phase 4 (2). There are also 5 NIH-funded research projects on Ventricular Arrhythmia, with $2.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 5NIH research projects
- 8Countries
Newest Ventricular Arrhythmia clinical trials
All recruiting trials (11)
-
Perioperative risks in adults with Brugada syndrome during anesthesia and related procedures
This registry follows adults with Brugada syndrome to see how often dangerous heart rhythms occur around anesthesia and up to 30 days after.
-
Dangerous heart rhythms after a heart attack
This study will see how survival and treatment differ for adults who develop sustained ventricular tachycardia or ventricular fibrillation during a heart attack, comparing events that occur within 48 hours to those that occur later.
-
Percutaneous stellate ganglion block for electrical storm
This trial will try a targeted nerve block using lidocaine and bupivacaine to stop repeated ventricular arrhythmias in adults whose electrical storm hasn't responded to initial treatments.
-
Real-time intracardiac ultrasound to guide ablation of ventricular arrhythmias
It tests whether using ultrasound inside the heart during PVC or VT ablation can reduce X-ray exposure for adults having these procedures.
-
Electrophysiological mapping to predict sudden cardiac death risk
It will test whether detailed electrical mapping of the left ventricle can better predict dangerous ventricular arrhythmias in adults with ischemic or non-ischemic cardiomyopathy and LVEF under 50% who are not already ICD candidates.
-
Carvedilol versus metoprolol succinate in people with heart failure and an implanted defibrillator
This study will test whether switching from metoprolol succinate to carvedilol reduces ICD therapies, heart-related hospitalizations, or cardiovascular death in adults with HFrEF and an ICD.
-
Predicting Ventricular Tachycardias in Patients After Myocarditis
This study is trying to see if the amount of scar tissue in the hearts of people who have recovered from myocarditis can help predict their risk of serious heart problems like sudden cardiac death or fast heartbeats.
-
Predicting Ventricular Tachycardia Events in Patients with Non-Ischemic Cardiomyopathy
This study is trying to see if certain heart imaging tests can help predict the risk of dangerous heart rhythms and sudden cardiac death in people with non-ischemic cardiomyopathy.
-
Evaluating endomyocardial biopsy and tailored treatments for pediatric inflammatory heart disease
This study is testing how a heart tissue sample and personalized treatments can help kids with inflammatory heart disease, especially those with myocarditis and heart rhythm issues.
-
Real-world experience of catheter ablation for atrial fibrillation
This study is trying to see how well catheter ablation works for treating atrial fibrillation in real-life settings and what the outcomes are for patients over time.
-
Registry for patients receiving implantable cardioverter defibrillators
This study is collecting information from hospitals about patients who receive implantable defibrillators to see how well these devices are helping people and to improve care for future patients.
NIH-funded research (5)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Understanding how heart nerves affect dangerous heart rhythms after a heart attack
This NIH grant studies how changes in the heart’s nerve signaling after a heart attack lead to dangerous rhythm problems, with the goal of finding ways to prevent them.
-
Dexterous needle ablation for ventricular arrhythmia guided by MRI
A new MRI-guided, robot-assisted catheter delivers deeper heart tissue ablation to treat ventricular tachycardia.
-
Real-Time AI-Driven Autonomic Neuromodulation to Prevent Ventricular Arrhythmias After Heart Attack
A new AI-guided system aims to adaptively modulate the autonomic nervous system in real time to prevent dangerous heart rhythm problems in people with a prior heart attack.
-
How aging, a heart calcium channel (TRPV4), and angiotensin II can cause dangerous heart rhythms
This research is seeing whether blocking a heart calcium channel called TRPV4 can reduce angiotensin II–related dangerous ventricular rhythms in aging hearts.
-
Understanding heart rhythms to improve treatment for arrhythmias
This study is working on a new way to understand heart rhythm problems in people with heart muscle disease by looking at how the heart is structured and how it works electrically, so doctors can better assess risks and personalize treatments for patients.
Related topics
Quick answers
How many Ventricular Arrhythmia clinical trials are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (3 trials), Italy (3 trials), Spain (3 trials), France (2 trials), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.